BMC Pediatrics | |
Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia | |
Jean-Marc Nuoffer3  Mathias Nelle1  Christoph Aebi2  Chiem Manh-Nhi3  Susanna Bigler2  Stefanie Frey1  Luregn J Schlapbach1  | |
[1] Neonatal and Pediatric Intensive Care Unit, Department of Pediatrics, University of Bern, 3010 Bern, Switzerland;Institute for Infectious Diseases, University of Bern, 3010 Bern, Switzerland;University Institute for Clinical Chemistry, University of Bern, 3010 Bern, Switzerland | |
关键词: vasopressin; neonate; copeptin; early-onset sepsis; asphyxia; | |
Others : 1172171 DOI : 10.1186/1471-2431-11-38 |
|
received in 2010-11-18, accepted in 2011-05-19, 发布年份 2011 | |
【 摘 要 】
Background
Vasopressin is one of the most important physiological stress and shock hormones. Copeptin, a stable vasopressin precursor, is a promising sepsis marker in adults. In contrast, its involvement in neonatal diseases remains unknown. The aim of this study was to establish copeptin concentrations in neonates of different stress states such as sepsis, chorioamnionitis and asphyxia.
Methods
Copeptin cord blood concentration was determined using the BRAHMS kryptor assay. Neonates with early-onset sepsis (EOS, n = 30), chorioamnionitis (n = 33) and asphyxia (n = 25) were compared to a control group of preterm and term (n = 155) neonates.
Results
Median copeptin concentration in cord blood was 36 pmol/l ranging from undetectable to 5498 pmol/l (IQR 7 - 419). Copeptin cord blood concentrations were non-normally distributed and increased with gestational age (p < 0.0001). Neonates born after vaginal compared to cesarean delivery had elevated copeptin levels (p < 0.0001). Copeptin correlated strongly with umbilical artery pH (Spearman's Rho -0.50, p < 0.0001), umbilical artery base excess (Rho -0.67, p < 0.0001) and with lactate at NICU admission (Rho 0.54, p < 0.0001). No difference was found when comparing copeptin cord blood concentrations between neonates with EOS and controls (multivariate p = 0.30). The highest copeptin concentrations were found in neonates with asphyxia (median 993 pmol/l). Receiver-operating-characteristic curve analysis showed that copeptin cord blood concentrations were strongly associated with asphyxia: the area under the curve resulted at 0.91 (95%-CI 0.87-0.96, p < 0.0001). A cut-off of 400 pmol/l had a sensitivity of 92% and a specifity of 82% for asphyxia as defined in this study.
Conclusions
Copeptin concentrations were strongly related to factors associated with perinatal stress such as birth acidosis, asphyxia and vaginal delivery. In contrast, copeptin appears to be unsuitable for the diagnosis of EOS.
【 授权许可】
2011 Schlapbach et al; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20150421021852635.pdf | 1871KB | download | |
Figure 6. | 29KB | Image | download |
Figure 5. | 37KB | Image | download |
Figure 4. | 35KB | Image | download |
Figure 3. | 46KB | Image | download |
Figure 2. | 41KB | Image | download |
20150216060519892.pdf | 402KB | download |
【 图 表 】
Figure 2.
Figure 3.
Figure 4.
Figure 5.
Figure 6.
【 参考文献 】
- [1]Treschan TA, Peters J: The vasopressin system: physiology and clinical strategies. Anesthesiology 2006, 105(3):599-612. quiz 639-540
- [2]Choong K, Kissoon N: Vasopressin in pediatric shock and cardiac arrest. Pediatr Crit Care Med 2008, 9(4):372-379.
- [3]Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, et al.: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358(9):877-887.
- [4]Choong K, Bohn D, Fraser DD, Gaboury I, Hutchison JS, Joffe AR, Litalien C, Menon K, McNamara P, Ward RE: Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med 2009, 180(7):632-639.
- [5]Filippi L, Poggi C, Serafini L, Fiorini P: Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatr 2008, 97(4):500-502.
- [6]Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z, Paret G: Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004, 5(2):116-118.
- [7]Meyer S, Gottschling S, Baghai A, Wurm D, Gortner L: Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 2006, 10(3):R71. BioMed Central Full Text
- [8]Bidegain M, Greenberg R, Simmons C, Dang C, Cotten CM, Smith PB: Vasopressin for refractory hypotension in extremely low birth weight infants. J Pediatr 2010, 157(3):502-504.
- [9]Struck J, Morgenthaler NG, Bergmann A: Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 2005, 26(12):2500-2504.
- [10]Morgenthaler NG, Struck J, Alonso C, Bergmann A: Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006, 52(1):112-119.
- [11]Jochberger S, Velik-Salchner C, Mayr VD, Luckner G, Wenzel V, Falkensammer G, Ulmer H, Morgenthaler N, Hasibeder W, Dunser MW: The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study. Intensive Care Med 2009, 35(3):489-497.
- [12]Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M: Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007, 28(2):219-226.
- [13]Russell JA: Vasopressin and its copilot copeptin in sepsis and septic shock. Crit Care Med 2009, 37(2):749-750.
- [14]Muller B, Morgenthaler N, Stolz D, Schuetz P, Muller C, Bingisser R, Bergmann A, Tamm M, Christ-Crain M: Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007, 37(2):145-152.
- [15]Wellmann S, Benzing J, Cippa G, Admaty D, Creutzfeldt R, Arlettaz Mieth R, Beinder E, Lapaire O, Morgenthaler NG, Haagen U, et al.: High Copeptin Concentrations in Umbilical Cord Blood after Vaginal Delivery and Birth Acidosis. J Clin Endocrin Me tab 2010, 95(11):5091-6.
- [16]Lawn JE, Cousens S, Zupan J: 4 million neonatal deaths: when? Where? Why? Lancet 2005, 365(9462):891-900.
- [17]van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, Fleer A, Krediet TG: Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010, 97(1):22-28.
- [18]van Rossum AM, Wulkan RW, Oudesluys-Murphy AM: Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004, 4(10):620-630.
- [19]Lawn J, Cousens S, Zupan J: 4 million neonatal deaths: When? Where? Why? The Lancet 2005, 365(9462):891-900.
- [20]Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, Kapellou O, Levene M, Marlow N, Porter E, et al.: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009, 361(14):1349-1358.
- [21]Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, et al.: Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347(4):240-247.
- [22]Kaukola T, Herva R, Perhomaa M, Paakko E, Kingsmore S, Vainionpaa L, Hallman M: Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants. Pediatr Res 2006, 59(3):478-483.
- [23]Sarnat HB, Sarnat MS: Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976, 33(10):696-705.
- [24]Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M: Copeptin, a Stable Peptide of the Arginine Vasopressin Precursor, Is Elevated in Hemorrhagic and Septic Shock. Shock 2007, 28(2):219-226.
- [25]Westermann I, Dunser MW, Haas T, Jochberger S, Luckner G, Mayr VD, Wenzel V, Stadlbauer KH, Innerhofer P, Morgenthaler N, et al.: Endogenous vasopressin and copeptin response in multiple trauma patients. Shock 2007, 28(6):644-649.
- [26]Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T, et al.: Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009, 54(1):60-68.
- [27]Harris TA, Healy GN, Colditz PB, Lingwood BE: Associations between serum cortisol, cardiovascular function and neurological outcome following acute global hypoxia in the newborn piglet. Stress 2009, 12(4):294-304.
- [28]Vogl SE, Worda C, Egarter C, Bieglmayer C, Szekeres T, Huber J, Husslein P: Mode of delivery is associated with maternal and fetal endocrine stress response. BJOG 2006, 113(4):441-445.
- [29]Ezgu FS, Atalay Y, Gucuyener K, Tunc S, Koc E, Ergenekon E, Tiras U: Neuron-specific enolase levels and neuroimaging in asphyxiated term newborns. J Child Neurol 2002, 17(11):824-829.
- [30]Gazzolo D, Abella R, Marinoni E, di Iorio R, Li Volti G, Galvano F, Frigiola A, Temporini F, Moresco L, Colivicchi M, et al.: New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009, 22(Suppl 3):57-61.
- [31]Torrance HL, Benders MJ, Derks JB, Rademaker CM, Bos AF, Van Den Berg P, Longini M, Buonocore G, Venegas M, Baquero H, et al.: Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009, 124(1):350-357.